{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:35:40Z","timestamp":1785800140549,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.msard.2022.103558","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T03:37:10Z","timestamp":1643600230000},"page":"103558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes"],"prefix":"10.1016","volume":"59","author":[{"given":"Birut\u0117","family":"Dir\u017eiuvien\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Mickevi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103558_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103115","article-title":"Early predictors of conversion to secondary progressive multiple sclerosis","volume":"54","author":"Barzegar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102691","article-title":"Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian patient registry","volume":"48","author":"Benjaminsen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102778","article-title":"Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: a central eastern European perspective from healthcare professionals","volume":"50","author":"Boyko","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0011","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.msard.2022.103558_bib0053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2019.01.045","article-title":"Prognostic factors of disability in relapsing remitting multiple sclerosis","volume":"30","author":"Briggs","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0007","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","article-title":"Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US department of defense administrative claims database","volume":"4","author":"Capkun","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000082784","article-title":"Poststroke fatigue: characteristics and related factors","volume":"19","author":"Choi-Kwon","year":"2005","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.msard.2022.103558_bib0039","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1468-1331.2011.03596.x","article-title":"Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis","volume":"19","author":"D'hooghe","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0043","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Pauli","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103558_bib0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.msard.2017.02.016","article-title":"Factors associated with adherence to disease modifying therapy in multiple sclerosis: an observational survey from a referral center in Lithuania","volume":"13","author":"Duchovskiene","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ane.12370","article-title":"Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis","volume":"132","author":"Fern\u00e1ndez-Mu\u00f1oz","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.103558_bib0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7224\/1537-2073.2015-070","article-title":"Fatigue and comorbidities in multiple sclerosis","volume":"18","author":"Fiest","year":"2016","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2022.103558_bib0021","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12955-017-0828-0","article-title":"Discriminative ability of quality of life measures in multiple sclerosis","volume":"15","author":"Fiest","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.msard.2022.103558_bib0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103558_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2011.12.007","article-title":"Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis","volume":"243","author":"Foster","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103558_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.68.2.150","article-title":"Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis","volume":"68","author":"Freeman","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103558_bib0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp-2019-322369","article-title":"Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis","volume":"91","author":"Geraldes","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103558_bib0046","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ane.12916","article-title":"Smoking and worsening disability in multiple sclerosis: a meta-analysis","volume":"138","author":"Heydarpour","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.103558_bib0054","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000311013","article-title":"Validation of a self-report comorbidity questionnaire for multiple sclerosis","volume":"35","author":"Horton","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2022.103558_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00866","article-title":"The impact of lifetime alcohol and cigarette smoking loads on multiple sclerosis severity","volume":"10","author":"Ivashynka","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102051","article-title":"The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland","author":"Kapica-Topczewska","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0015","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/1352458518769837","article-title":"The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis","volume":"25","author":"Kobelt","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103558_bib0049","article-title":"Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset","author":"Koch","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0001","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0008","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103558_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18115588","article-title":"Early-onset alcohol dependence and multiple sclerosis: diagnostic challenges","volume":"18","author":"Luca","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.msard.2022.103558_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148573","article-title":"Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors","volume":"11","author":"Marck","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2022.103558_bib0009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","article-title":"Cumulative impact of comorbidity on quality of life in MS","volume":"125","author":"Marrie","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.103558_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.msard.2022.103558_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103558_bib0027","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1352458514564485","article-title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103558_bib0028","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103558_bib0004","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103558_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7224\/1537-2073.2016-086","article-title":"Comorbidity in multiple sclerosis: some answers, more questions","volume":"18","author":"Marrie","year":"2016","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2022.103558_bib0037","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0026","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","volume":"90","author":"McKay","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103558_bib0003","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/ane.12854","article-title":"Self-assessments and determinants of HRQoL in a German MS population","volume":"137","author":"Nickel","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.103558_bib0047","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1212\/WNL.0000000000004949","article-title":"Smoking affects the interferon beta treatment response in multiple sclerosis","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103558_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.msard.2012.02.004","article-title":"Weight status and disability in multiple sclerosis: an examination of bi-directional associations over a 24-month period","volume":"1","author":"Pilutti","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0024","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1191\/1352458503ms929oa","article-title":"Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales","volume":"9","author":"Riazi","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103558_bib0022","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.bmb.a011611","article-title":"Assessing obesity: classification and epidemiology","volume":"53","author":"Seidell","year":"1997","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.msard.2022.103558_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101958","article-title":"Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: a pilot randomized controlled trial","volume":"40","author":"Siengsukon","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7525-3-16","article-title":"Role of health-related quality of life measures in the routine care of people with multiple sclerosis","volume":"3","author":"Solari","year":"2005","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.msard.2022.103558_bib0048","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","article-title":"Vascular comorbidities in the onset and progression of multiple sclerosis","volume":"347","author":"Tettey","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.103558_bib0036","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000442203","article-title":"Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis","volume":"46","author":"Tettey","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2022.103558_bib0052","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2016-315037","article-title":"An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event","volume":"88","author":"Tettey","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103558_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ene.13297","article-title":"Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships","volume":"24","author":"Thormann","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.103558_bib0018","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","article-title":"Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality","volume":"89","author":"Thormann","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103558_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11910-016-0706-x","article-title":"Mental health comorbidity in ms: depression, anxiety, and bipolar disorder","volume":"16","author":"Turner","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2022.103558_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102801","article-title":"Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis","volume":"50","author":"Wesnes","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103558_bib0038","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10072-015-2326-7","article-title":"Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies","volume":"36","author":"Zhu","year":"2015","journal-title":"Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:58:00Z","timestamp":1761901080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":51,"alternative-id":["S2211034822000736"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103558","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103558"}}